Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C16H13N3O3
CAS Number:
Molecular Weight:
295.29
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
EC Number:
250-635-4
Beilstein/REAXYS Number:
759809
MDL number:
Product Name
Mebendazole, analytical standard, ≥98% (HPLC)
InChI key
OPXLLQIJSORQAM-UHFFFAOYSA-N
InChI
1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21)
SMILES string
COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c3ccccc3
grade
analytical standard
assay
≥98% (HPLC)
technique(s)
HPLC: suitable
gas chromatography (GC): suitable
application(s)
forensics and toxicology
pharmaceutical (small molecule)
format
neat
Quality Level
Looking for similar products? Visit Product Comparison Guide
Application
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
General description
Mebendazole is a benzimidazole carbamate derivative, which is an anthelmintic agent.
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
The Antimicrobial Drugs (2000)
Sara Carlert et al.
Molecular pharmaceutics, 9(10), 2903-2911 (2012-09-08)
The purpose of this study was to investigate in vivo intestinal precipitation of a model drug mebendazole, a basic BCS class II drug, using dogs with intestinal stomas for administration or sampling. After oral administration of a solution with an
Peter Nygren et al.
Journal of cancer research and clinical oncology, 139(12), 2133-2140 (2013-10-19)
In the present study, we screened a compound library containing 1,600 clinically used compounds with the aim to identify compounds, which potentially could be repositioned for colon cancer therapy. Two established colon cancer cell lines were tested using the fluorometric
Sivanesan Dakshanamurthy et al.
Journal of medicinal chemistry, 55(15), 6832-6848 (2012-07-12)
The most effective way to move from target identification to the clinic is to identify already approved drugs with the potential for activating or inhibiting unintended targets (repurposing or repositioning). This is usually achieved by high throughput chemical screening, transcriptome
Monica Longo et al.
Reproductive toxicology (Elmsford, N.Y.), 36, 78-87 (2013-01-05)
Filarial diseases affect millions of people in poverty-stricken areas. In 2011, an investigation of the potential of flubendazole as a safe, highly efficacious, and field-usable macrofilaricidal drug was begun by Drug for Neglected Diseases initiative. As part of the preclinical
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service